Surgical conversion after anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) therapy in N3 stage ALK-positive non-small cell lung cancer: a report of three cases
- DOI
- 10.21037/tlcr-2026-0982
- Published
- 2026-10
- Container
- Translational Lung Cancer Research
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/tlcr-2026-0982,
title = {Surgical conversion after anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) therapy in N3 stage ALK-positive non-small cell lung cancer: a report of three cases},
author = {Beike Xiao and Hao Guo and Jiatao Zhang and Xue-Ning Yang},
year = {2026},
journal = {Translational Lung Cancer Research},
doi = {10.21037/tlcr-2026-0982},
url = {https://doi.org/10.21037/tlcr-2026-0982}
}RIS
TY - JOUR TI - Surgical conversion after anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) therapy in N3 stage ALK-positive non-small cell lung cancer: a report of three cases AU - Beike Xiao AU - Hao Guo AU - Jiatao Zhang AU - Xue-Ning Yang PY - 2026 JO - Translational Lung Cancer Research DO - 10.21037/tlcr-2026-0982 UR - https://doi.org/10.21037/tlcr-2026-0982 ER -
APA
Xiao, B., Guo, H., Zhang, J., & Yang, X. (2026). Surgical conversion after anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) therapy in N3 stage ALK-positive non-small cell lung cancer: a report of three cases. Translational Lung Cancer Research. https://doi.org/10.21037/tlcr-2026-0982
Source records
- crossref · retrieved 2026-11-09T18:01:10.920Z